Lee Gilho
Department of Urology, Dankook University Medical College, Cheonan, Korea.
World J Mens Health. 2015 Aug;33(2):103-8. doi: 10.5534/wjmh.2015.33.2.103. Epub 2015 Aug 19.
While hematospermia is mainly caused by genitourinary inflammatory disorders, very few studies have been published on prostatitis-associated hematospermia (PAH) diagnosed using robust prostatitis evaluation methods. Therefore, we have evaluated the incidence of PAH by using systematic methods for evaluating prostatitis.
We evaluated 37 hematospermia patients from a single hospital over the last five years. We classified the patients into PAH versus hematospermia without any evidence of prostatitis (HWP) by using a NIH-Chronic Prostatitis Symptom Index questionnaire and expressed prostatic secretion studies.
The mean age was 55.89±14.87 years, and the patients were grouped into two groups: one group had 12 HWP patients and the other 25 PAH patients. PAH patients were further sub-classified: chronic bacterial prostatitis (3 patients), chronic nonbacterial prostatitis (10 patients), prostadynia (7 patients), and asymptomatic prostatitis (5 patients). We found Enterococcus faecalis in the three chronic bacterial prostatitis patients. We could not find any statistically significant difference between the PAH and the HWP groups in terms of the age interval, serum prostate-specific antigen level, and prostate volume. Even though there was no statistically significant difference in the items about urination between the two groups, we found a statistically significant difference in the quality of life (QoL) impact for the patients in this study.
Two-thirds of the hematospermia patients were associated with some evidence of prostatitis. Further, the patients with PAH revealed poor QoL compared with the patients with HWP. Therefore, we must evaluate the presence of prostatitis in hematospermia patients and alleviate the prostatitis-associated symptoms to improve their QoL.
虽然血精症主要由泌尿生殖系统炎症性疾病引起，但使用可靠的前列腺炎评估方法诊断的前列腺炎相关性血精症（PAH）的研究报道极少。因此，我们采用系统性方法评估前列腺炎，以评价PAH的发病率。
我们评估了过去五年内来自同一家医院的37例血精症患者。通过使用美国国立卫生研究院慢性前列腺炎症状指数问卷并进行前列腺分泌物检查，将患者分为PAH组和无任何前列腺炎证据的血精症组（HWP）。
患者平均年龄为55.89±14.87岁，分为两组：一组有12例HWP患者，另一组有25例PAH患者。PAH患者进一步细分：慢性细菌性前列腺炎（3例）、慢性非细菌性前列腺炎（10例）、前列腺痛（7例）和无症状性前列腺炎（5例）。我们在3例慢性细菌性前列腺炎患者中发现了粪肠球菌。在年龄区间、血清前列腺特异性抗原水平和前列腺体积方面，PAH组和HWP组之间未发现任何统计学上的显著差异。尽管两组在排尿相关项目上无统计学显著差异，但我们发现本研究中患者的生活质量（QoL）影响存在统计学显著差异。
三分之二的血精症患者与某些前列腺炎证据相关。此外，与HWP患者相比，PAH患者的QoL较差。因此，我们必须评估血精症患者中前列腺炎的存在情况，并缓解与前列腺炎相关的症状，以改善他们的QoL。
